BioAmber Financials

$19.2 M

Mkt cap, 31-Oct-2017
Net income (Q1, 2017)(1.4 M)
EBIT (Q1, 2017)(10.6 M)
Closing share price, 31-Oct-20170.5
Cash, 31-Mar-20175.3 M

Market Value

Revenue/Financials

Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

2.7 m1.5 m2.2 m

Revenue growth, %

(42%)41%

Sales and marketing expense

4.7 m4.5 m4 m2.9 m

General and administrative expense

9.8 m10.7 m10.6 m9.5 m

Operating expense total

14.5 m15.1 m14.6 m12.4 m

EBIT

41.2 m35.2 m38.5 m(29.6 m)

EBIT margin, %

1545%2282%1774%

Pre tax profit

33.7 m47.2 m41.2 m(28.3 m)

Income tax expense

102.8 k75.4 k(3.8 k)25.6 k

Net Income

(33.8 m)(47.3 m)(41.2 m)(28.4 m)

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

414.6 k469.3 k367.2 k1.5 m2.5 m

Sales and marketing expense

1.7 m954.2 k1.2 m1.1 m920.7 k1.2 m583.5 k479.4 k641.5 k

R&D expense

6 m

General and administrative expense

2.9 m2.4 m2.6 m3 m2.2 m2.6 m3 m1.8 m4.9 m

Operating expense total

4.6 m3.4 m3.8 m4.1 m9.1 m3.8 m3.6 m2.2 m5.5 m

EBIT

10.4 m8.3 m8.5 m10.9 m9.9 m8.5 m(7.3 m)(6.6 m)(10.6 m)

EBIT margin, %

2503%1766%2304%583%(290%)

Pre tax profit

14.1 m8.4 m8.9 m14.8 m8.5 m12.5 m2.9 m(6.7 m)(1.4 m)

Income tax expense

9.4 k18 k33.3 k10.6 k(28.7 k)6 k12.3 k(28.7 k)12 k

Net Income

(14.1 m)(8.5 m)(9 m)(23.8 m)(32.3 m)(12.5 m)(9.6 m)(16.3 m)(1.4 m)

Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

83.7 m7 m16.2 m

Accounts Receivable

755 k476.9 k978.6 k986.9 k

Inventories

2.4 m1.8 m1.7 m4.5 m

Current Assets

95 m57.1 m10.8 m31.4 m

PP&E

13.6 m88.7 m122.5 m121.6 m

Goodwill

692.8 k625.4 k625.4 k625.4 k

Total Assets

114.1 m152.4 m143.1 m161.3 m

Accounts Payable

6 m

Current Liabilities

17.8 m22.9 m29.7 m45.3 m

Long-term debt

23.2 m34.7 m29.8 m29 m

Total Debt

29 m

Total Liabilities

75.3 m

Additional Paid-in Capital

177.3 m220.5 m258.8 m280.8 m

Retained Earnings

(161.5 m)(198.3 m)(220.8 m)

Total Equity

67.1 m57.5 m

Debt to Assets Ratio

0.2 x

Financial Leverage

1.7 x2.6 x

Quarterly

USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

48.7 m34.2 m14.1 m5.5 m15.9 m5.3 m

Accounts Receivable

406.6 k226.9 k1.4 m2.2 m4 m293.3 k

Inventories

1.3 m1.3 m2.2 m2.8 m2.5 m4.8 m

Current Assets

54.7 m38 m20.1 m11.9 m23.4 m20.8 m

PP&E

127 m125.5 m129.1 m128.2 m125.8 m121.6 m

Goodwill

625.4 k625.4 k625.4 k625.4 k625.4 k625.4 k

Total Assets

190.1 m173.2 m157.7 m148.7 m157.6 m150.7 m

Accounts Payable

17.2 m16.4 m4.7 m5.1 m5.5 m4.6 m

Current Liabilities

34.6 m35.4 m18.6 m19.1 m29.3 m17.5 m

Long-term debt

46.2 m40.8 m28.1 m26.5 m30.7 m30.2 m

Additional Paid-in Capital

256.5 m257.4 m271.6 m272.4 m273.4 m296.9 m

Retained Earnings

(183.7 m)(190.5 m)(209.2 m)(204.4 m)(210.6 m)(220.7 m)

Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(33.8 m)(47.3 m)(41.2 m)(28.4 m)

Accounts Receivable

(158.8 k)278.1 k(581.1 k)(5 k)

Inventories

(521.1 k)1.2 m(8.1 k)(2.8 m)

Cash From Operating Activities

(27.5 m)(22.5 m)(32.2 m)(37.6 m)

Purchases of PP&E

(12.8 m)

Cash From Investing Activities

(12.8 m)(85 m)(64.8 m)(668 k)

Long-term Borrowings

(25 m)(16.1 m)(15.3 m)

Cash From Financing Activities

99.9 m78.7 m54.9 m47.2 m

Interest Paid

2.9 m2.7 m

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(14.1 m)(8.5 m)(9 m)(23.8 m)(32.3 m)(12.5 m)(9.6 m)(16.3 m)(1.4 m)

Accounts Receivable

(47.6 k)292.9 k56.5 k70.4 k(474 k)(312.1 k)(1.1 m)(2.9 m)698.9 k

Inventories

(110.6 k)985.3 k(178.1 k)489 k494.4 k(346.4 k)(1 m)(738.8 k)(305.5 k)

Cash From Operating Activities

(3.1 m)(2.3 m)(5.9 m)(15.6 m)(22.5 m)(20.3 m)(25.7 m)(33.1 m)(10.6 m)

Purchases of PP&E

(20 m)

Cash From Investing Activities

(19.3 m)(26.7 m)(29.5 m)(52.8 m)(62.9 m)(26.1 k)(363.8 k)(540.4 k)(254.9 k)

Long-term Borrowings

(2.8 m)(585.4 k)(2.4 m)(4.8 m)(14.1 m)(18.9 m)

Cash From Financing Activities

2.6 m56.1 m11.4 m66.8 m70.5 m27 m24.2 m42.2 m

Interest Paid

434.7 k924.9 k1.7 m700.5 k